Decitabine and sickle cell disease: molecular therapy for a molecular disease.
Saunthararajah
Yogen
Y
University of Illinois at Chicago, Chicago, Illinois 60612, USA. yogen@uic.edu
D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use; D019175:DNA Methylation; D000077209:Decitabine; D044127:Epigenesis, Genetic; D005914:Globins / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans